|
Thrombin
Citations 1-10 of 55 total displayed.
|
Most recent content
(27 Nov 2007):
|
- Editorials
Ablation for Atrial Fibrillation: Can We Decrease Thromboembolism Without Increasing the Risk for Bleeding?
- Samuel J. Asirvatham
Circulation 2007; 116: 2517-2519, doi:10.1161/CIRCULATIONAHA.107.741454
[Full text]
|
Past content
(since Nov 2000):
|
- Molecular Cardiology
Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and Hypertrophy
- Rafal Pawlinski, Michael Tencati, Craig R. Hampton, Tetsuro Shishido, Tara A. Bullard, Liam M. Casey, Patricia Andrade-Gordon, Matthias Kotzsch, Denise Spring, Thomas Luther, Jun-ichi Abe, Timothy H. Pohlman, Edward D. Verrier, Burns C. Blaxall, and Nigel Mackman
Circulation 116: 2298 -2306; published online before print as doi:10.1161/CIRCULATIONAHA.107.692764
[Abstract]
[Full text]
- Articles
Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and Hypertrophy
- Rafal Pawlinski, Michael Tencati, Craig R. Hampton, Tetsuro Shishido, Tara A. Bullard, Liam M. Casey, Patricia Andrade-Gordon, Matthias Kotzsch, Denise Spring, Thomas Luther, Jun-ichi Abe, Timothy H. Pohlman, Edward D. Verrier, Burns C. Blaxall, and Nigel Mackman
Circulation published October 29, 2007, doi:10.1161/CIRCULATIONAHA.107.692764
[Abstract]
- Contemporary Reviews in Cardiovascular Medicine
Contemporary Management of Postcatheterization Pseudoaneurysms
- Geoffrey W. Webber, James Jang, Susan Gustavson, and Jeffrey W. Olin
Circulation 2007; 115: 2666-2674, doi:10.1161/CIRCULATIONAHA.106.681973
[Full text]
- Heart Failure
Hemodynamic Modulation of Endocardial Thromboresistance
- Navin K. Kapur, Clayton B. Deming, Sunil Kapur, Ce Bian, Hunter C. Champion, J. Kevin Donahue, David A. Kass, and Jeffrey J. Rade
Circulation 115: 67 -75; published online before print as doi:10.1161/CIRCULATIONAHA.106.640698
[Abstract]
[Full text]
- Articles
Hemodynamic Modulation of Endocardial Thromboresistance
- Navin K. Kapur, Clayton B. Deming, Sunil Kapur, Ce Bian, Hunter C. Champion, J. Kevin Donahue, David A. Kass, and Jeffrey J. Rade
Circulation published December 26, 2006, doi:10.1161/CIRCULATIONAHA.106.640698
[Abstract]
- Vascular Medicine
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology: A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity
- Christopher K. Dyke, Steven R. Steinhubl, Neal S. Kleiman, Richard O. Cannon, Laura G. Aberle, Min Lin, Shelley K. Myles, Chiara Melloni, Robert A. Harrington, John H. Alexander, Richard C. Becker, and Christopher P. Rusconi
Circulation 114: 2490 -2497; published online before print as doi:10.1161/CIRCULATIONAHA.106.668434
[Abstract]
[Full text]
- Articles
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology. A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity
- Christopher K. Dyke, Steven R. Steinhubl, Neal S. Kleiman, Richard O. Cannon, Laura G. Aberle, Min Lin, Shelley K. Myles, Chiara Melloni, Robert A. Harrington, John H. Alexander, Richard C. Becker, and Christopher P. Rusconi
Circulation published November 13, 2006, doi:10.1161/CIRCULATIONAHA.106.668434
[Abstract]
- Vascular Medicine
Direct Vascular Effects of Protease-Activated Receptor Type 1 Agonism In Vivo in Humans
- Ingibjörg J. Gudmundsdóttir, Ian L. Megson, Jillian S. Kell, Christopher A. Ludlam, Keith A.A. Fox, David J. Webb, and David E. Newby
Circulation 114: 1625 -1632; published online before print as doi:10.1161/CIRCULATIONAHA.106.638478
[Abstract]
[Full text]
- Articles
Direct Vascular Effects of Protease-Activated Receptor Type 1 Agonism In Vivo in Humans
- Ingibjörg J. Gudmundsdóttir, Ian L. Megson, Jillian S. Kell, Christopher A. Ludlam, Keith A.A. Fox, David J. Webb, and David E. Newby
Circulation published October 2, 2006, doi:10.1161/CIRCULATIONAHA.106.638478
[Abstract]
|
|
